Azucena structures sourcing and market-development opportunities across six cardiovascular territories. This is a business portfolio—not a retail catalogue—and each opportunity remains subject to technical, regulatory and commercial qualification.
Thin-strut cobalt-chromium stent systems with biodegradable-polymer and healing-focused coating concepts, reviewed for trackability, scaffolding, drug-release profile and size coverage.
Balloon-expandable ePTFE-covered cobalt-chromium platforms considered for specialist coronary requirements, with attention to crossing profile, flarability, delivery length and pressure limits.
Semi-compliant lesion-preparation and non-compliant high-pressure post-dilatation families, including conventional and conical geometries.
Core-to-tip and shaping-ribbon wire concepts with hydrophilic distal sections, PTFE-coated proximal shafts and radiopaque distal coils.
Self-expanding closure devices for PFO, ASD, VSD and PDA applications, built from braided nitinol wire with platinum nanocoating and dedicated delivery systems.
Supra-annular, self-expanding nitinol valve concepts with bovine-pericardial leaflets and controlled positioning or recapture features.
Balloon dilatation catheter platforms reviewed for structural-heart preparation and valvuloplasty workflows, with model-specific dimensions and pressure ratings.
Balloon guiding, selective microcatheter and distal-access concepts intended to build a stable pathway through tortuous neurovascular anatomy.
Clot-retrieval technologies assessed within acute ischemic-stroke intervention pathways and always subject to specialist clinical use and local authorization.
Peripheral and crossover access technologies considered for selective navigation, therapeutic delivery and support across complex vascular territories.
Microsphere-based embolization concepts reviewed by particle range, delivery compatibility, suspension behavior and intended vascular territory.
PTFE-lined hybrid-braid catheter concepts designed around torque response, kink resistance, backup support and a broad tip-shape portfolio.
Diagnostic catheter families with curve options for coronary and peripheral visualization, evaluated alongside guidewire, sheath and contrast-delivery compatibility.
Tapered dilators, anti-kink radiopaque sheaths, hemostasis valves, side ports and stopcock configurations for controlled arterial or venous access.
Sterile single-use pressure-generation and monitoring systems for angioplasty, stent deployment and valvuloplasty workflows.
Monofilament and braided closure materials mapped by composition, absorption profile, tensile retention, needle configuration and procedural role.
Complementary tissue-support and hemostatic materials for qualified cardiovascular and general-surgery supply discussions.
This portfolio describes an indicative business-development scope. It is not a retail offer, a clinical recommendation, or a claim of representation. Product status, approved indications, current technical documentation and supply rights are verified separately for each market.
Product intelligence becomes useful only when it can support a credible route to market.
Our trading modelPortfolio positioning, market prioritization, distributor development and commercial feedback across target Middle Eastern markets.
Structured product sourcing, documentation coordination, supply planning and long-term portfolio development.